These pathological changes impair the phosphorylation of insulin receptor (IR) substrates and disrupt the PI3K/AKT signaling pathway, thereby weakening the metabolic effects of insulin and ultimately leading to insulin resistance [109]. The gene discussed is INSR; the disease is Insulin resistance.